Joanna Trubicka

Scientific degree: MD dr hab.

Scientific position: assistant professor

Department: Department of Pathology/Laboratory of Oncopathology and Medical Biostructure


OrcID No: 0000-0002-9848-3674

  • since 2016 – assistant Professor – Pathology Unit/Laboratory of Oncopathology and Medical Biostructure
  • 2010-2016 – assistant Professor – Medical Genetics Department
  • 2008 – Doctor of Medical Sciences in the field of medical biology, Pomeranian Medical Academy, Medical Faculty
  • 2002-2010 – trainee, volunteering, doctoral student, specialist in a category of technical and scientific staff, research group member, teaching for the first-year students of the Medical Faculty Pomeranian Medical University
  • 2002 – Master of Science in Biology, specialty: molecular biology, University of Adam Mickiewicz, Faculty of Biology

Qualifications and trainings:

  • 2016 – licenced laboratory diagnostician, post-graduate studies in medical laboratory analysis, University of Adam Mickiewicz, Pharmaceutical Faculty
  • 12.2013 – Charité Klinikum, Institut für Medizinische Genetik und Humangenetik, Berlin, Germany, Department of Medical Genetics – visiting scientist
  • 2008 – International Agency for Research on Cancer, Lyon, France Marie Curie fellowship number MTKD-CT-2004-510114, participation in the project entitled: “Identification of new cancer susceptibility genes by linkage analyses in Polish families with aggregation of breast or colorectal cancers”

Research interests:

  • molecular background of pediatric central nervous system tumors (germline and somatic mutations)
  • molecular diagnostics of solid childhood cancer (germline and somatic mutations)
  • mocelular background of epilepsy associated with tuberous sclerosis complex and cortical dysplasia
  • molecular markers (DNA sequence alterations and chromosomal rearrangements) in childhood  lymphoblastic lymphomas
  • molecular background of mitochondrial and metabolic disorders in children
  • genetic predisposition in renal, breast, colon and lung cancers.